Prognostic Value of Preoperative Serum Carcinoembryonic Antigen for Overall Survival and Recurrence-Free Survival in Resectable Thymic Epithelial Tumors
- PMID: 36217838
- PMCID: PMC9558855
- DOI: 10.1177/15330338221119340
Prognostic Value of Preoperative Serum Carcinoembryonic Antigen for Overall Survival and Recurrence-Free Survival in Resectable Thymic Epithelial Tumors
Abstract
Introduction: Tumor markers have been shown to be closely related to the long-term survival of patients with cancer and the recurrence of various malignant tumors. However, their role in thymic epithelial tumors (TETs) remains to be elucidated. We aimed to investigate whether the preoperative tumor biomarkers carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) could serve as independent predictors of postoperative prognosis in patients with TETs. Materials and Methods: We retrospectively included a total of 111 patients with TETs who underwent thymectomy at our hospital. Cox regression analysis was used to evaluate the statistical significance of CEA and NSE as independent predictors of overall survival (OS) and recurrence-free survival (RFS). Kaplan-Meier curves were used to present the results of our survival analyses. Results: Cox regression analysis showed that T stage, World Health Organization (WHO) histologic type, tumor size, and CEA levels served as independent prognostic factors for OS (P < .05). Whereas for RFS, multivariate analysis showed that only T stage, WHO histologic type, and drinking history were independently associated with it (P < .05). Conclusion: Our study found that preoperative serum CEA levels and tumor size may be strong predictors of postoperative OS in patients with TETs.
Keywords: carcinoembryonic antigen; overall survival; prognosis; recurrence-free survival; thymic epithelial tumor; tumor biomarker.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures





Similar articles
-
Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study.BMC Cancer. 2022 Nov 17;22(1):1183. doi: 10.1186/s12885-022-10234-x. BMC Cancer. 2022. PMID: 36397047 Free PMC article.
-
Surgical outcomes of 215 patients with thymic epithelial tumors: A single-center experience.Thorac Cancer. 2020 Jul;11(7):1840-1847. doi: 10.1111/1759-7714.13464. Epub 2020 May 8. Thorac Cancer. 2020. PMID: 32384230 Free PMC article. Clinical Trial.
-
Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.World J Gastroenterol. 2019 Sep 7;25(33):4945-4958. doi: 10.3748/wjg.v25.i33.4945. World J Gastroenterol. 2019. PMID: 31543685 Free PMC article.
-
Prognostic factors for overall survival after surgical resection in patients with thymic epithelial tumors: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Sep 30;101(39):e30867. doi: 10.1097/MD.0000000000030867. Medicine (Baltimore). 2022. PMID: 36181069 Free PMC article.
-
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.Lung Cancer. 2012 May;76(2):138-43. doi: 10.1016/j.lungcan.2011.11.012. Epub 2011 Dec 6. Lung Cancer. 2012. PMID: 22153832 Review.
References
-
- Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the Art. J Clin Oncol. 1999;17(7):2280‐2289. - PubMed
-
- Marx A, Ströbel P, Badve SS, et al. ITMIG consensus statement on the use of the WHO histological Classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014;9(5):596‐611. - PubMed
-
- Scorsetti M, Leo F, Trama A, et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016;99:332‐350. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources